BSX vs DXCM
Boston Scientific Corporation · DexCom, Inc.
Relative return (rebased to 100)
Key stats
| Metric | BSX | DXCM |
|---|---|---|
| Price | $44.92 | $89.53 |
| Market Cap | $65.10B | $33.79B |
| P/E | 22.51 | 40.40 |
| P/B | 2.61 | 12.89 |
| P/S | 3.24 | 7.25 |
| ROE | 11.6% | 31.9% |
| Net Margin | 14.4% | 17.9% |
| Gross Margin | 69.0% | 60.1% |
| Revenue Growth | 19.9% | 15.6% |
| Dividend Yield | — | — |
| EPS | $2.00 | $2.22 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.